We are live on ! Find out more
MESO icon

Mesoblast

68 hedge funds and large institutions have $49.2M invested in Mesoblast in 2025 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 24 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

96% more capital inflows, than outflows

Capital inflows: $28.4M | Capital outflows: $14.5M

70% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 10

60% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 15

11% more funds holding

Funds holding: 61 → 68 (+7)

9% more call options, than puts

Call options by funds: $6.22M | Put options by funds: $5.69M

0.47% more ownership

Funds ownership: 2.64% → 3.11% (+0.47%)

Holders
68
Holders Change
+7
Holders Change %
+11.48%
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
24
Reduced
15
Closed
10
Calls
$6.22M
Puts
$5.69M
Net Calls
+$525K
Net Calls Change
+$1.09M

MESO Hedge Fund Activity: Q1 2025 in Review

68 of the 7,491 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q1 2025, worth a combined $49.2M — down 18% from $59.9M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new MESO positions and 10 closed out — a net gain of 7 holders — while 24 added to existing stakes and 15 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $8.02M. The largest seller was Bank of America, cutting an estimated $4.19M.

  • 68 institutional investors held Mesoblast (MESO) as of Q1 2025, up from 61 in Q4 2024.
  • Funds reported $49.2M of Mesoblast stock for Q1 2025, down 18% quarter-over-quarter.
  • 17 funds opened new Mesoblast positions in Q1 2025 and 10 closed out, a net change of +7 holders.
  • The largest Mesoblast buyer in Q1 2025 was Citadel Advisors, an estimated $8.02M added.
  • The largest Mesoblast seller in Q1 2025 was Bank of America, an estimated $4.19M sold.

Based on aggregated 13F filings for Q1 2025.